JPMorgan Chase & Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$183M Buy
1,721,294
+59,252
+4% +$6.29M 0.01% 670
2025
Q1
$206M Buy
1,662,042
+74,501
+5% +$9.25M 0.02% 626
2024
Q4
$196M Buy
1,587,541
+72,007
+5% +$8.87M 0.01% 625
2024
Q3
$169M Sell
1,515,534
-22,788
-1% -$2.54M 0.01% 704
2024
Q2
$164M Buy
1,538,322
+43,784
+3% +$4.67M 0.01% 679
2024
Q1
$180M Buy
1,494,538
+97,254
+7% +$11.7M 0.02% 649
2023
Q4
$172M Sell
1,397,284
-28,757
-2% -$3.54M 0.02% 621
2023
Q3
$185M Sell
1,426,041
-270,971
-16% -$35.1M 0.02% 541
2023
Q2
$210M Sell
1,697,012
-430,992
-20% -$53.4M 0.02% 521
2023
Q1
$311M Sell
2,128,004
-723,490
-25% -$106M 0.04% 376
2022
Q4
$454M Sell
2,851,494
-659,347
-19% -$105M 0.06% 295
2022
Q3
$468M Buy
3,510,841
+133,780
+4% +$17.8M 0.07% 265
2022
Q2
$527M Buy
3,377,061
+87,895
+3% +$13.7M 0.07% 250
2022
Q1
$512M Buy
3,289,166
+67,374
+2% +$10.5M 0.06% 284
2021
Q4
$410M Buy
3,221,792
+325,479
+11% +$41.5M 0.05% 361
2021
Q3
$377M Buy
2,896,313
+11,341
+0.4% +$1.48M 0.05% 368
2021
Q2
$512M Buy
2,884,972
+987,143
+52% +$175M 0.06% 315
2021
Q1
$312M Sell
1,897,829
-3,307
-0.2% -$544K 0.04% 413
2020
Q4
$314M Buy
1,901,136
+41,098
+2% +$6.78M 0.05% 369
2020
Q3
$260M Buy
1,860,038
+119,823
+7% +$16.7M 0.04% 375
2020
Q2
$192M Sell
1,740,215
-24,790
-1% -$2.74M 0.04% 430
2020
Q1
$176M Sell
1,765,005
-145,199
-8% -$14.5M 0.04% 379
2019
Q4
$285M Sell
1,910,204
-254,940
-12% -$38.1M 0.05% 321
2019
Q3
$277M Sell
2,165,144
-88,726
-4% -$11.4M 0.06% 328
2019
Q2
$311M Sell
2,253,870
-8,289
-0.4% -$1.14M 0.06% 304
2019
Q1
$323M Buy
2,262,159
+324,080
+17% +$46.3M 0.07% 287
2018
Q4
$240M Buy
1,938,079
+25,906
+1% +$3.21M 0.06% 327
2018
Q3
$321M Buy
1,912,173
+106,291
+6% +$17.9M 0.06% 305
2018
Q2
$311M Buy
1,805,882
+168,836
+10% +$29.1M 0.06% 297
2018
Q1
$247M Buy
1,637,046
+121,449
+8% +$18.3M 0.05% 343
2017
Q4
$204M Sell
1,515,597
-157,136
-9% -$21.2M 0.04% 390
2017
Q3
$248M Buy
1,672,733
+267,325
+19% +$39.6M 0.05% 338
2017
Q2
$219M Buy
1,405,408
+410,031
+41% +$63.8M 0.05% 357
2017
Q1
$144M Buy
995,377
+141,417
+17% +$20.5M 0.03% 452
2016
Q4
$93.1M Buy
853,960
+139,169
+19% +$15.2M 0.02% 567
2016
Q3
$86.8M Sell
714,791
-118,549
-14% -$14.4M 0.02% 553
2016
Q2
$118M Sell
833,340
-241,391
-22% -$34.1M 0.03% 474
2016
Q1
$140M Buy
1,074,731
+179,454
+20% +$23.4M 0.04% 428
2015
Q4
$126M Buy
895,277
+56,500
+7% +$7.94M 0.03% 463
2015
Q3
$111M Buy
838,777
+73,339
+10% +$9.74M 0.03% 488
2015
Q2
$135M Buy
765,438
+34,007
+5% +$5.99M 0.03% 476
2015
Q1
$126M Buy
731,431
+176,757
+32% +$30.5M 0.03% 527
2014
Q4
$90.8M Buy
554,674
+137,680
+33% +$22.5M 0.02% 637
2014
Q3
$67M Sell
416,994
-73,407
-15% -$11.8M 0.02% 727
2014
Q2
$72.1M Sell
490,401
-48,551
-9% -$7.14M 0.02% 669
2014
Q1
$74.7M Buy
538,952
+20,701
+4% +$2.87M 0.02% 635
2013
Q4
$65.6M Buy
518,251
+209,706
+68% +$26.5M 0.02% 659
2013
Q3
$28.4M Buy
308,545
+157,999
+105% +$14.5M 0.01% 1054
2013
Q2
$10.3M Buy
+150,546
New +$10.3M ﹤0.01% 1545